Back
Milestone Pharmaceuticals Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
MIST
Milestone Pharmaceuticals
Last Price:
1.86
Seasonality Move:
-2.66%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Milestone Pharmaceuticals Price Quote
$1.86
Milestone Pharmaceuticals Key Stats
Sell
50
Milestone Pharmaceuticals (MIST)
is a Sell
Day range:
$1.73 - $1.91
52-week range:
$1.12 - $3.52
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.78%
Volume:
605.8K
Avg. volume:
412.7K
1-year change:
-18.42%
Market cap:
$90.7M
Revenue:
$1M
EPS:
$-0.81
How Much Does Milestone Pharmaceuticals Make?
Data Unavailable
Is Milestone Pharmaceuticals Growing As A Company?
Data Unavailable
Milestone Pharmaceuticals Stock Price Performance
-
Did Milestone Pharmaceuticals Stock Go Up Last Month?
Milestone Pharmaceuticals share price went up by 24.83% last month -
Did MIST's Share Price Rise Over The Last Year?
MIST share price fell by -18.42% over the past 1 year
What Is Milestone Pharmaceuticals 52-Week High & Low?
-
What Is Milestone Pharmaceuticals’s 52-Week High Share Price?
Milestone Pharmaceuticals has traded as high as $3.52 over the past 52 weeks -
What Is Milestone Pharmaceuticals’s 52-Week Low Share Price?
Milestone Pharmaceuticals has traded as low as $1.12 over the past 52 weeks
Milestone Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Milestone Pharmaceuticals?
-
How Much Debt Does Milestone Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Milestone Pharmaceuticals Have?
Cash and short term investments quarterly total is $76.4M -
What Is Milestone Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.45
Is Milestone Pharmaceuticals Cash Flow Positive?
-
What Is MIST Cash Flow From Operations?
Cash flow from operations (TTM) is -$31.8M -
What Is Milestone Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $32.1M -
What Is Milestone Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $2.6M
Milestone Pharmaceuticals Return On Invested Capital
Data Unavailable
Milestone Pharmaceuticals Earnings Date & Stock Price
-
What Is Milestone Pharmaceuticals's Stock Price Today?
A single share of MIST can be purchased today for 1.86 -
What Is Milestone Pharmaceuticals’s Stock Symbol?
Milestone Pharmaceuticals trades on the nasdaq under the ticker symbol: MIST -
When Is Milestone Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Milestone Pharmaceuticals is scheduled on March 21, 2025 -
When Is MIST's next ex-dividend date?
Milestone Pharmaceuticals's next ex-dividend date is November 21, 2024 -
How To Buy Milestone Pharmaceuticals Stock?
You can buy Milestone Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Milestone Pharmaceuticals Competitors
-
Who Are Milestone Pharmaceuticals's Competitors?
Below is a list of companies who compete with Milestone Pharmaceuticals or are related in some way:
Milestone Pharmaceuticals Dividend Yield
-
What Is MIST Dividend Yield?
Milestone Pharmaceuticals’s dividend yield currently is 0% -
What Is Milestone Pharmaceuticals’s Payout Ratio?
Milestone Pharmaceuticals’s payout ratio is 0% -
When Did Milestone Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Milestone Pharmaceuticals’s Dividend Per Share?
Milestone Pharmaceuticals pays a dividend of $0.00 per share
Milestone Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 22.22% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 13.00 |
| Upside from Last Price: | 598.92% |